Madrid And Oeiras

MADRID and OEIRAS, Portugal, March 16, 2011 - Digna Biotech and Biotecnol (The Consortium) announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I (CT-I).